ANDA 85934, held by Sandoz. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 85934 (Butabarbital Sodium), held by Sandoz, was first approved by FDA on Sep 16, 1994, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 16, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarbital Sodium30MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
| Sep 16, 1994 | Original application | Approved | None posted |
| May 28, 1985 | Supplement 9Manufacturing | Approved | None posted |
| Aug 11, 1983 | Supplement 11Manufacturing | Approved | None posted |
| Nov 12, 1982 | Supplement 10Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters